Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all.

20 Sep 2012

Congress can help improve WASH, survival for children worldwide

David Winder, chief executive of WaterAid USA, highlights the findings of the recently released UNICEF report on child mortality in this Huffington Post "Impact" blog post, saying the decrease in annual number of child deaths "is great news, but is tempered by sobering statistics, especially for children in sub-Saharan Africa," who continue to face high rates of mortality.

19 Sep 2012

Extreme temperatures affect cardiac mortality

Extreme temperatures experienced during cold spells and heat waves may increase a person’s risk for premature death from cardiovascular disease, say researchers.

19 Sep 2012

Vitamin D deficiency common in critically ill children

Children who are critically ill frequently have low serum levels of vitamin D, report researchers.

18 Sep 2012

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.

18 Sep 2012

Thalidomide effective in treating disabling cough among people with idiopathic pulmonary fibrosis

In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that taking thalidomide significantly reduced the cough and improved quality of life.

18 Sep 2012

Roundup: Mont. settlement money to pay for uninsured's prescription drugs; Physician assistants' role in Mass.; Atlanta to cut worker premiums

The Montana attorney general's office says nearly $1 million collected in drug company settlements will be used to help pay for prescription medicine for people who are uninsured and underinsured. Attorney General Steve Bullock said in a statement Thursday the money came from settlements dating back to 2010 with four drug companies accused of inflating the wholesale prices of drugs paid by Medicare and Medicaid.

18 Sep 2012

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Immune Targeting Systems Limited, an emerging leader in the development of vaccines that promote T-cell responses against viruses and cancers, today announces compelling data from two Phase I clinical trials of FlunisynTM, the Company's lead vaccine programme which elicits potent immune responses against multiple strains of influenza-A virus.

18 Sep 2012

UCSF-led research team targets physiological factors that lead to asthma attack

A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding the two most significant biological responses that lead to an asthma attack.

18 Sep 2012

Scientists solve co-crystal structure of human antibody that can neutralize influenza viruses

Scientists from The Scripps Research Institute and Sea Lane Biotechnologies have solved the co-crystal structure of a human antibody that can neutralize influenza viruses in a unique way.

17 Sep 2012

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

17 Sep 2012

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, presented Phase 2 clinical data of JX-594 delivered first intravenously and subsequently through intra-tumoral route demonstrating safety as well as disease control and tumor responses in patients with hepatocellular carcinoma (liver cancer, HCC).

17 Sep 2012

Consumer Genetics Conference to take place from October 3-5

Advancements in sequencing and diagnostics technology are the underlying elements driving the genomic revolution. With the free-falling cost of sequencing, richer reference data and improved interpretation methods, the use of personal genomics is beginning to take greater root in clinical practice.

15 Sep 2012

Scientists identify genetic building blocks behind human heart's subtle control system

Since the early 1900s, scientists have been wondering how birds and mammals could have developed almost identical conduction systems independently of each other when their common ancestor was a cold-blooded reptile with a sponge-like inner heart that has virtually no conduction bundles.

15 Sep 2012

SLU study: Many U.S. schools not prepared for bioterrorism attacks, outbreaks of pandemics

Many U.S. schools are not prepared for bioterrorism attacks, outbreaks of emerging infectious diseases or pandemics, despite the recent 2009 H1N1 influenza pandemic that resulted in more than 18,000 deaths worldwide, Saint Louis University researchers say.

15 Sep 2012

Research roundup: Patients' experiences at safety-net hospitals

Each week KHN reporter Ankita Rao compiles a selection of recently released health policy studies and briefs.

15 Sep 2012

Progress on child survival rate since 2000

The pace of reducing child deaths has accelerated sharply since 2000, according to new data released by UNICEF, the World Health Organization, the World Bank and the UN Population Division.

14 Sep 2012

Objective response rate promising after crizotinib for NSCLC

More than half of the latest evaluated participants from the ongoing phase II PROFILE 1005 trial of crizotinib against ALK-positive advanced non-small-cell lung cancer, achieved an objective tumor response, report researchers.

14 Sep 2012

Global child mortality rates fall 41% since 1990, U.N. reports

"Child mortality worldwide has fallen 41 percent since 1990, the result of myriad improvements in nutrition, access to vaccines and antibiotics, cleaner deliveries, better care of infants immediately after birth, and the use of insecticide-treated mosquito nets," according to "the findings of a report released Wednesday by three United Nations agencies and the World Bank," the Washington Post reports.

14 Sep 2012

U-M develops new guidelines for family physicians to evaluate urinary leakage in women

Millions of women experience a loss of bladder control, or urinary incontinence, in their lifetime. It's a common and often embarrassing problem that many patients don't bring up with their doctors - and when they do, it may be mentioned as a casual side note during a visit for more pressing medical issues.

14 Sep 2012

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

Congress can help improve WASH, survival for children worldwide

Extreme temperatures affect cardiac mortality

Vitamin D deficiency common in critically ill children

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Thalidomide effective in treating disabling cough among people with idiopathic pulmonary fibrosis

Roundup: Mont. settlement money to pay for uninsured's prescription drugs; Physician assistants' role in Mass.; Atlanta to cut worker premiums

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

UCSF-led research team targets physiological factors that lead to asthma attack

Scientists solve co-crystal structure of human antibody that can neutralize influenza viruses

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Consumer Genetics Conference to take place from October 3-5

Scientists identify genetic building blocks behind human heart's subtle control system

SLU study: Many U.S. schools not prepared for bioterrorism attacks, outbreaks of pandemics

Research roundup: Patients' experiences at safety-net hospitals

Progress on child survival rate since 2000

Objective response rate promising after crizotinib for NSCLC

Global child mortality rates fall 41% since 1990, U.N. reports

U-M develops new guidelines for family physicians to evaluate urinary leakage in women

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in